Nye regler for harmoniseret klassificering og mærkning af kemiske stoffer

1)

Følgende indgange indsættes i tabellen i rækkefølge efter deres indeksnumre: Indeksnr. Kemisk navn EF nr. CAS nr. Klassificering Mærkning Specifikke koncentrationsgrænser, M-faktorer og ATE-værdier Noter Fareklasse- og kategorikode(r) Faresætningskode(r) Piktogram-, signalordskode(r) Faresætningskode(r) Suppl. faresætningskode(r) »005-022-00-4 perborsyre, natriumsalt [1] perborsyre, natriumsalt, monohydrat [2] perborsyre (HBO(O2)), natriumsalt, monohydrat [3] natriumperoxoborat [4] natriumperborat [5] 234-390-0 [1] 234-390-0 [2] - [3] - [4] 239-172-9 [5] 11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] - [4] 15120-21-5 [5] Ox. Sol. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Dam. 1 H272 H360FD H331 H302 H335 H318 GHS03 GHS08 GHS06 GHS05 Dgr H272 H360FD H331 H302 H335 H318 indånding: ATE = 0,75 mg/L (støv eller tåger) oral: ATE = 890 mg/kg kropsvægt Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2 H319: 14 % ≤ C < 22 % 11« »005-023-00-X perborsure(H3BO2(O2)), mononatriumsalt-trihydrat [1] perborsyre, natriumsalt, tetrahydrat [2] perborsyre (HBO(O2)), natriumsalt, tetrahydrat [3] natriumperoxoborat, hexahydrat [4] 239-172-9 [1] 234-390-0 [2] - [3] - [4] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] - [4] Repr. 1B Acute Tox. 4 STOT SE 3 Eye Dam. 1 H360FD H332 H335 H318 GHS08 GHS05 GHS07 Dgr H360FD H332 H335 H318 indånding: ATE = 1,2 mg/L (støv eller tåger) Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2 H319: 22 % ≤ C < 36 % 11« »005-024-00-5 natriumperoxometaborat 231-556-4 7632-04-4 Ox. Sol. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Dam. 1 H272 H360FD H331 H302 H335 H318 GHS03 GHS08 GHS06 GHS05 Dgr H272 H360FD H331 H302 H335 H318 indånding: ATE = 0,62 mg/L (støv eller tåger) oral: ATE = 730 mg/kg kropsvægt Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2 H319: 14 % ≤ C < 22 % 11« »006-104-00-2 flervæggede kulstofrør (syntetisk grafit i rørform) med en geometrisk rørdiameter på mellem ≥ 30 nm og < 3 μm, en længde på ≥ 5 μm og et højde/bredde-forhold på > 3:1, herunder flervæggede kulstof-nanorør (»MWC(N)T«) — — Carc. 1B STOT RE 1 H350i H372 (lunge) (indånding) GHS08 Dgr H350i H372 (lunge) (indånding) STOT RE 1; H372: C ≥ 1 %; STOT RE 2; H373: 0,1 % ≤ C < 1 %« »029-026-00-0 kobber; [specifikt overfladeareal > 0,67 mm2/mg] 231-159-6 7440-50-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 10 M = 1« »047-004-00-9 sølv i massiv form: [partikeldiameter ≥ 1 mm] 231-131-3 7440-22-4 Repr. 2 STOT RE 2 H361f H373 (nervesystem) GHS08 Wng H361f H373 (nervesystem)« »047-005-00-4 sølv i pulverform: [partikeldiameter > 100 nm og < 1 mm] 231-131-3 7440-22-4 Repr. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H361f H373 (nervesystem) H400 H410 GHS08 GHS09 Wng H361f H373 (nervesystem) H410 M = 10 M = 10« »047-006-00-X sølv i nanoform: [partikeldiameter > 1 nm og ≤ 100 nm] 231-131-3 7440-22-4 Repr. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H361f H373 (nervesystem) H400 H410 GHS08 GHS09 Wng H361f H373 (nervesystem) H410 M = 1 000 M = 1 000 « »603-247-00-8 reaktionsmasse af 1,3-dioxan-5-ol og 1,3-dioxolan-4-ylmethanol - - Repr. 1B H360Df GHS08 Dgr H360Df« »605-042-00-9 α-methyl-1,3-benzodioxol-5-propionaldehyd [1] (S)-α-methyl-1,3-benzodioxol-5-propionaldehyd; (2S)-3-(1,3-benzodioxol-5-yl)-2-methylpropanal [2] (R)-α-methyl-1,3-benzodioxol-5-propionaldehyd; (2R)-3-(1,3-benzodioxol-5-yl)-2-methylpropanal [3] 214-881-6 [1] - [2] - [3] 1205-17-0 [1] 737776-68-0 [2] 737776-59-9 [3] Skin Sens. 1B H317 GHS07 Wng H317« »605-043-00-4 2,4-dimethylcyclohex-3-en-1-carbaldehyd [1] (1α,2α,5α)-2,5-dimethylcyclohex-3-en-1-carbaldehyd [2] 2,6-dimethylcyclohex-3-en-1-carbaldehyd [3] 3,5-dimethylcyclohex-3-en-1-carbaldehyd [4] 3,6-dimethylcyclohex-3-en-1-carbaldehyd [5] 4,6-dimethylcyclohex-3-en-1-carbaldehyd [6] reaktionsmasse af 3,5-dimethylcyclohex-3-en-1-carbaldehyd og 2,4-dimethylcyclohex-3-en-1-carbaldehyd [7] dimethylcyclohex-3-en-1-carbaldehyd [8] dimethylcyclohex-3-en-1-carbaldehyd [9] 1,2,4(eller 1,3,5)-trimethylcyclohex-3-en-1-carbaldehyd [10] 1,3,4-trimethylcyclohex-3-en-1-carbaldehyd [11] 2,2,4-trimethylcyclohex-3-en-1-carbaldehyd [12] 2,4,6-trimethylcyclohex-3-en-carbaldehyd [13] isocyclocitral [14] 3,5,6-trimethylcyclohex-3-en-1-carbaldehyd [15] 4,6,6-trimethylcyclohex-3-en-1-carbaldehyd [16] 268-264-1 [1] 252-395-6 [2] - [3] 268-263-6 [4] 267-186-5 [5] 253-139-6 [6] - [7] 248-742-6 [8] 272-113-5 [9] 276-055-1 [10] - [11] - [12] 215-833-7 [13] 215-638-7 [14] 266-810-3 [15] - [16] 68039-49-6 [1] 35145-02-9 [2] 6975-94-6 [3] 68039-48-5 [4] 67801-65-4 [5] 36635-35-5 [6] - [7] 27939-60-2 [8] 68737-61-1 [9] 71832-78-5 [10] 40702-26-9 [11] 1726-47-2 [12] 1423-46-7 [13] 1335-66-6 [14] 67634-07-5 [15] 6754-27-4 [16] Skin Sens. 1 H317 GHS07 Wng H317« »606-156-00-1 acetoneoxim 204-820-1 127-06-0 Carc. 1B Acute Tox. 4 STOT SE 3 STOT RE 2 Eye Dam. 1 Skin Sens. 1 H350 H312 H336 H373 (blodsystem) H318 H317 GHS08 GHS07 GHS05 Dgr H350 H312 H336 H373 (blodsystem) H318 H317 dermal: ATE = 1 100 mg/kg kropsvægt« »606-157-00-7 (3E)-dec-3-en-2-on — 18402-84-1 Acute Tox. 4 Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 2 H332 H304 H315 H411 GHS07 GHS08 GHS09 Dgr H332 H304 H315 H411 EUH071 indånding: ATE = 1,5 mg/l (støv eller tåger)« »606-158-00-2 2-dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-on 438-340-0 119344-86-4 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360Df H400 H410 GHS08 GHS09 Dgr H360Df H410 M = 1 M = 1« »607-770-00-2 2,3-epoxypropylneodecanoat 247-979-2 26761-45-5 Muta. 2 Skin Sens. 1A H341 H317 GHS08 GHS07 Wng H341 H317 Skin Sens. 1A; H317: C ≥ 0,001 %« »607-771-00-8 benthiavalicarb-isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluor-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamat — 177406-68-7 Carc. 1B Repr. 2 Skin Sens. 1 Aquatic Chronic 2 H350 H361fd H317 H411 GHS08 GHS07 GHS09 Dgr H350 H361fd H317 H411« »607-772-00-3 hexylsalicylat 228-408-6 6259-76-3 Repr. 2 Skin Sens. 1 H361d H317 GHS08 GHS07 Wng H361d H317« »607-773-00-9 7-oxabicyclo[4.1.0]hept-3-ylmethyl-7-oxabicyclo[4.1.0]heptan-3-carboxylat 219-207-4 2386-87-0 Muta. 2 STOT RE 2 Skin Sens. 1 H341 H373 (næsehule) H317 GHS08 GHS07 Wng H341 H373 (næsehule) H317« »607-774-00-4 tetranatrium-4-amino-5-hydroxy-3,6-bis [[4-[[2-(sulfonatooxy) ethyl]sulfonyl]phenyl]azo]naphthalen-2,7-disulfonat [1] Reaktionsprodukter af 4-amino-5-hydroxynaphthalen-2,7-disulfonsyre, dobbeltbundet med diazoteret 2-[(4-aminophenyl)sulfonyl]ethylhydrogensulfat, natriumsalte [2] dinatrium-4-amino-5-hydroxy-3,6-bis{[4-(vinylsulfonyl)phenyl]diazenyl}naphthalen-2,7-disulfonat [3] 241-164-5 [1] - [2] - [3] 17095-24-8 [1] - [2] 100556-82-9 [3] Resp. Sens. 1A Skin Sens. 1 H334 H317 GHS08 Dgr H334 H317« »607-775-00-X natrium-3-(allyloxy)-2-hydroxypropansulfonat 258-004-5 52556-42-0 Repr. 1B Eye Dam. 1 H360F H318 GHS08 GHS05 Dgr H360F H318« »609-074-00-4 1,4-dichlor-2-nitrobenzen 201-923-3 89-61-2 Carc. 1B H350 GHS08 Dgr H350« »611-182-00-1 2-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]ethanol 271-183-4 68516-81-4 Skin Sens. 1A H317 GHS07 Wng H317 Skin Sens. 1A; H317: C ≥ 0,001 %« »612-299-00-0 fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidin - 67306-00-7 Repr. 2 Acute Tox. 4 Acute Tox. 4 STOT SE 3 STOT SE 3 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H332 H302 H335 H336 H373 (nervesystem, øjne, lunger) H315 H318 H317 H400 H410 GHS08 GHS07 GHS05 GHS09 Dgr H361d H332 H302 H335 H336 H373 (nervesystem, øjne, lunger) H315 H318 H317 H410 indånding: ATE = 1,2 mg/L (støv eller tåger) oral: ATE = 1 330 mg/kg kropsvægt M = 1 000 M = 10 000 « »613-350-00-X 1H-benzotriazol 202-394-1 95-14-7 Aquatic Chronic 2 H411 GHS09 Wng H411« »613-351-00-5 methyl-1H-benzotriazol 249-596-6 29385-43-1 Aquatic Chronic 2 H411 GHS09 Wng H411« »616-243-00-6 N,N'-methylendiacrylamid 203-750-9 110-26-9 Muta. 1B H340 GHS08 Dgr H340« »617-024-00-8 tert-butyl 2-ethylperoxyhexanoat 221-110-7 3006-82-4 Repr. 1B Skin Sens. 1 H360FD H317 GHS08 GHS07 Dgr H360FD H317«

2)

De indgange, der svarer til indeksnumrene 005-005-00-1, 016-022-00-9, 016-094-00-1, 029-019-01-X, 601-037-00-0, 604-020-00-6, 605-001-00-5, 607-001-00-0, 607-043-00-X, 607-094-00-8, 607-198-00-3, 607-315-00-8, 607-432-00-4, 613-272-00-6, 616-127-00-5 og 617-008-00-0, erstattes af følgende: Indeksnr. Kemisk navn EF nr. CAS nr. Klassificering Mærkning Specifikke koncentrationsgrænser, M-faktorer og ATE-værdier Noter Fareklasse- og kategorikode(r) Faresætningskode(r) Piktogram-, signalordskode(r) Faresætningskode(r) Suppl. faresætningskode(r) »005-005-00-1 trimethylborat 204-468-9 121-43-7 Flam. Liq. 3 Repr. 1B Acute Tox. 4* H226 H360FD H312 GHS02 GHS08 GHS07 Dgr H226 H360FD H312 11« »016-022-00-9 ethanethiol; ethylmercaptan 200-837-3 75-08-1 Flam. Liq. 1 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H224 H331 H302 H400 H410 GHS02 GHS06 GHS09 Dgr H224 H331 H302 H410 indånding: ATE = 7,1 mg/l (dampe) oral: ATE = 680 mg/kg kropsvægt« »016-094-00-1 svovl 231-722-6 7704-34-9 Skin Irrit. 2 H315 GHS07 Wng H315« »029-019-01-X kobberflager (med et ydre lag af alifatisk syre) Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H302 H319 H400 H410 GHS06 GHS09 Dgr H331 H302 H319 H410 indånding: ATE = 0,733 mg/l (støv eller tåger) oral: ATE = 500 mg/kg kropsvægt M = 10 M = 1« »601-037-00-0 n-hexan 203-777-6 110-54-3 Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT SE 3 STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 H225 H361f*** H304 H336 H372 (nervesystem) H315 H411 GHS02 GHS08 GHS07 GHS09 Dgr H225 H361f*** H304 H336 H372 (nervesystem) H315 H411« »604-020-00-6 biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl 201-993-5 90-43-7 Carc. 2 Skin Corr. 1 Eye Dam. 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H351 H314 H318 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H351 H314 H317 H410 M = 1 M = 1« »605-001-00-5 formaldehyd … % 200-001-8 50-00-0 Carc. 1B Muta. 2 Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1A H350 H341 H330 H302 H314 H317 GHS08 GHS06 GHS05 Dgr H350 H341 H330 H302 H314 H317 EUH071 indånding: ATE = 100 ppmV (gasser) oral: ATE = 500 mg/kg kropsvægt STOT SE 3; H335: C ≥ 5 % Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2 H315: 5 % ≤ C < 25 % Eye Irrit. 2 H319: 5 % ≤ C < 25 % B, D, F« »607-001-00-0 myresyre … % 200-579-1 64-18-6 Flam. Liq. 3 Met. Corr. 1 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Eye Dam. 1 H226 H290 H331 H302 H314 H318 GHS02 GHS05 GHS06 Dgr H226 H290 H331 H302 H314 EUH071 indånding: ATE = 7,4 mg/l (dampe) oral: ATE = 500 mg/kg kropsvægt Flam. Liq. 3; H226: C > 85 % Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; 314: 10 % ≤ C < 90 % Skin Irrit. 2 H315: 2 % ≤ C < 10 % Eye Dam. 1; H318: C ≥ 10 % Eye Irrit. 2 H319: 2 % ≤ C < 10 %« B »607-043-00-X dicamba (ISO); 2,5-dichlor-6-methoxybenzoesyre; 3,6-dichlor-2-methoxybenzoesyre 217-635-6 1918-00-9 Acute Tox. 4 Acute Tox. 4 STOT SE 3 STOT SE 3 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 2 H332 H302 H335 H336 H318 H400 H411 GHS07 GHS05 GHS09 Dgr H332 H302 H335 H336 H318 H410 indånding: ATE = 4,0 mg/L (støv eller tåger) oral: ATE = 1 500 mg/kg kropsvægt M = 1« »607-094-00-8 pereddikesyre ... % 201-186-8 79-21-0 Org. Perox. D Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 H242 H330 H310 H301 H314 H400 H410 GHS02 GHS06 GHS05 GHS09 Dgr H242 H330 H310 H301 H314 H410 EUH071 indånding: ATE = 0,2 mg/L (støv eller tåger) dermal: ATE = 60 mg/kg kropsvægt oral: ATE = 80 mg/kg kropsvægt STOT SE 3; H335: C ≥ 1 % M = 10 M = 100 B, D, T« »607-198-00-3 propyl-3,4,5-trihydroxybenzoat 204-498-2 121-79-9 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 oral: ATE = 1 700 mg/kg kropsvægt M = 1 M = 1« »607-315-00-8 glyphosat (ISO); N- (phosphonomethyl)glycin 213-997-4 1071-83-6 Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411« »607-432-00-4 S-metolachlor (ISO); 2-chlor-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamid; (R a S a)-2-chlor-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamid [indeholder 80-100 % 2-chlor-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamid og 0-20 % 2-chlor-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamid] — 87392-12-9 Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H317 H410 EUH066 M = 10 M = 10« »613-272-00-6 pyraclostrobin (ISO); methyl-N-(2-{[1-(4-chlorphenyl)-1H-pyrazol-3-yl]oxymethyl}phenyl)-N-methoxycarbamat - 175013-18-0 Repr. 2 Acute Tox. 3 Acute Tox. 4 STOT SE 3 STOT RE 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H361d H331 H302 H335 H373 (lever, mave-tarm-kanal, næsehule) H315 H400 H410 GHS08 GHS06 GHS09 Dgr H361d H331 H302 H335 H373 (lever, mave-tarm-kanal, næsehule) H315 H410 indånding: ATE = 0,58 mg/l (støv eller tåger) oral: ATE = 450 mg/kg kropsvægt M = 100 M = 100« »616-127-00-5 reaktionsmasse af N,N'-ethan-1,2-diylbis(decanamid) og 12-hydroxy-N-[2-[(1-oxodecyl)amino]ethyl]octadecanamid og N,N'-ethan-1,2-diylbis(12-hydroxyoctadecanamid) [1] reaktionsmasse af N,N'-ethan-1,2-diylbis(decanamid) og 12-hydroxy-N-[2-[(1-oxodecyl)amino]ethyl]octadecanamid [2] 430-050-2 [1] - [2] - [1] - [2] Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M = 100 M = 10« »617-008-00-0 dibenzoylperoxid; benzoylperoxid 202-327-6 94-36-0 Org. Perox. B Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H241 H319 H317 H400 H410 GHS01 GHS02 GHS07 GHS09 Dgr H241 H319 H317 H410 M = 10 M = 10«

3)

De indgange, der svarer til indeksnumrene 005-017-00-7, 005-017-01-4, 005-018-00-2, 005-018-01-X, 005-019-00-8, 005-019-01-5 og 029-024-00-X, udgår.